Life Science News

  • Demand for HealthCheck, Contakt's marquee solution, continues to grow in the face of the Omicron variant-driven wave of COVID-19 and increasing vaccine mandates and requirements in numerous jurisdictions
  • HealthCheck has added over 20 new customers and has renewed over 130 customer subscriptions within the past 3 months, with nearly 800 customers in total, servicing over 100,000 users in the US alone
  • HealthCheck alone generated nearly $1.35 million CAD in revenue in calendar 2021 (figures unaudited)
  • HealthCheck 3.0 has been officially released, adding vaccine passport, COVID-19 test tracking capabilities, and several improvements to its population management dashboard.
  • Contakt is looking to broaden its portfolio entering 2022, looking to acquire and partner with other SaaS companies in the healthcare sector and beyond

Contakt World Technologies Corp. (CSE: HELP) (OTC Pink: TLOOF) (FSE: B2I0) (the "Company", "Contakt" or "Contakt World"), a SaaS company committed to delivering a diverse suite of subscription based software solutions for healthcare and other industries, is pleased to provide a general corporate update for its shareholders.

HealthCheck
Contakt's COVID Compliance Solution, Stratum Health ("HealthCheck"), has seen significant growth in new customers and renewals over the past 90 days, primarily driven by the recent surge of COVID-19 Omicron variant globally. HealthCheck has added nearly 20 new enterprise clients since October, and new sales continue to growth month over month. Many of HealthCheck's largest clients, including Atlanta County Public Schools, with close to 50,000 users (students and school staff), have extended or renewed their annual contracts, continuing to drive revenue.

HealthCheck generated over $1.35 million CAD in revenue in calendar 2021 (figures unaudited). Contakt expects HealthCheck to continue to grow in 2022, with inbound sales inquiries increasing due to vaccine mandates and surges of COVID-19. HealthCheck currently has over 800 clients and over 100,000 active users on its platform. HealthCheck has initiated a robust marketing campaign, targeting businesses, schools and non-profit organizations across multiple jurisdictions and, specifically, those in which vaccine mandates remain in effect.

Contakt is pleased to announce that it has released the 3.0 version of its HealthCheck App and admin dashboard, in response to market demand and feedback from existing and new customers. All HealthCheck customers now have access to the platform's new vaccine passport and COVID-19 test tracking features, in addition to our established HIPPA-compliant daily symptom screening check based on the CDC's most updated guidelines. Customers interested in these new features can contact the Company's customer support for training and activation. In addition to these new important upgrades, several security and improved functionality features were deployed.

Portfolio Expansion
As the Company enters 2022, Contakt is looking to drive growth by broadening its product portfolio through acquisition, partnerships, and joint ventures. The Company is also actively pursuing SaaS solutions that it can grow by leveraging its existing customer base. While the Company is putting a specific focus on "health-tech" solutions, it is also looking beyond to other rapidly growing industries, including the metaverse, and software leveraging enterprise blockchain technology, where it can achieve rapid growth.

"We have been very pleased with the growth of HealthCheck in 2021 and are looking forward to continued growth in 2022. The HealthCheck team continues to drive new sales and deliver new product functionality to address a market that continues to grow and evolve. While we hope that the COVID-19 pandemic will soon come to an end as the virus becomes endemic, we do expect HealthCheck to remain relevant for years to come as we expand our tracking and health record keeping capabilities to address new diseases," stated Zayn Kalyan, Chief Executive Officer of Contakt World. "Beyond HealthCheck, we are actively looking at a number of SaaS companies in healthcare and other industries where we believe that Company will be able to derive revenue and profit, with the ultimate goal of driving shareholder value," Mr. Kalyan further stated.

Update on Management Cease Trade Order
On December 30, 2021 the Company announced (the "Default Announcement") that, due to certain audit delays related to its recent cross-border acquisition, the Company was unable to file its audited annual financial statements, management's discussion and analysis and related Chief Executive Officer and Chief Financial Officer certificates for the year ended August 31, 2021 (collectively, the "Required Filings") before the December 29, 2021 filing deadline.

The Company is providing this bi-weekly default status report in accordance with National Policy 12-203 Management Cease Trade Orders ("NP 12-203"). Until such time as the Company files the Required Filings and the MCTO has been revoked, the Company intends to follow the provisions of the alternative reporting guidelines set out in NP 12-203, including the issuance of bi-weekly default status reports in the form of news releases.

The Company confirms that, other than as disclosed herein,:

  1. there have been no changes to the information contained in the Default Announcement that would reasonably be expected to be material to an investor;

  2. there have been no failures by the Company to fulfill its stated intentions with respect to satisfying the provisions of the alternative reporting guidelines under NP 12-203;

  3. there has not been, nor is there anticipated to be, any specified default subsequent to the default which is the subject of the Default Announcement; and

  4. there is no other material information concerning the affairs of the Company that has not been generally disclosed.

The Company is working expeditiously on the steps required to complete the Required Filings and anticipates that it will be in a position to remedy the default by filing the Required Filings by early February 2022. The MCTO will be in effect until the Required Filings are made.

Correction in Stock Option Cancellations
The Company also confirms it was a total of only 1,350,000 stock options which were cancelled.

Other Recent Related News from Contakt World:
Contakt World Launches Sales Representative Program to Continue to Grow Revenue for Its Cash Flow Positive HealthCheck Screening Tool and Vaccine Passport Solution

Contakt World to Offer Vaccine Passport and Verification Platform to Employers, Events and Organizations, Including Customers of Recently Acquired HealthCheck App

Contakt World Announces Acquisition of HealthCheck, a SaaS Health Screening App for Students, Customers, Employees, and Visitors

To Learn More:
If you are an organization seeking daily health screening and vaccine passports, vaccine wallets, or vaccine credentials, schedule a demo by visiting https://www.stratumhealth.io/. Our team will work with your organization to define the product that better suits your needs.

About Contakt World
Contakt World's mission is to develop or acquire and deliver software as a service (SaaS) that improves access to, efficiencies within, and quality of healthcare and other industries in all its forms. Contakt World's portfolio presently includes HealthCheck by Stratum which is used in over 1,000 locations, and Portum Pass https://contakt.world/portum/. Contakt World is actively looking to broaden its software portfolio through acquisitions, partnerships, and joint ventures. The Company is currently looking to broaden its industry scope, looking beyond healthcare, to other industries that can benefit from its current and future solutions.

Sign up for investor updates from Contakt World including updates in the field of vaccine passports and symptom screening by visiting https://contakt.world/help.

Contakt World Contact
Zayn Kalyan
Interim CEO and Director
Direct: 778-938-3367

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

Forward-Looking Statements Disclaimer

This press release contains "forward-looking information" within the meaning of applicable securities laws ("forward-looking statements"). Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "projects", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements, including statements respecting: expected growth at HealthCheck in 2022; HealthCheck's rollout of marketing campaigns; the new functionality and reception of the new HealthCheck 3.0 platform; the Company's plans to broaden its portfolio and pursue SaaS solutions; the Company's hopes that the Covid-19 pandemic will end soon; expected need for HealthCheck's solutions after the Covid-19 pandemic has ended; and timing for completion of the Required Filings. Although forward-looking statements contained in this press release are based upon what management of Contakt World believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The forward-looking statements may also be affected by risks and uncertainties in the business of Contakt World, including those described in the Company's public filings available on www.SEDAR.com. Contakt World undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/111426

News Provided by Newsfile via QuoteMedia

HELP:CNX
Contakt World Announces DTC Eligibility and OTC Pink Listing

Contakt World Announces DTC Eligibility and OTC Pink Listing

Contakt World Technologies Corp. (CSE: HELP) (OTC Pink: TLOOF) (FSE: B2I0) (the "Company", "Contakt" or "Contakt World"), a SaaS company committed to delivering a diverse suite of subscription based software solutions for healthcare and other industries, is pleased to announce that its CUSIP 20177G108 is now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC") in the United States. Its common shares have commenced trading on the OTC Pink Market in the USA under the symbol "TLOOF" (the "Listing"). The Company's common shares will continue to trade on the Canadian Securities Exchange (CSE) under the symbol "HELP." The Company expects the Listing to provide greater exposure, visibility and trading convenience for U.S. investors, resulting in enhanced liquidity and extended reach.

Other Recent Related News from Contakt World:

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Contakt World Provides Company Update as it Continues to Expand its Portfolio of SaaS Solutions and Commercial Presence in the US Market

Contakt World Provides Company Update as it Continues to Expand its Portfolio of SaaS Solutions and Commercial Presence in the US Market

Contakt World is well-positioned to continue to take a leading role as a provider of SaaS solutions designed to meet Federal Vaccine Mandates imposed by the United States

  • A vaccine mandate was recently enacted in the United States for all Federal employees
  • The private sector is following suit, creating demand for Contakt World's portfolio
  • Health Check and Portum's app offers the public and private sector a unique, integrated solution

Contakt World Technologies Corp. (CSE: HELP) (OTC Pink: TLOOF) (FSE: B2I0) (the "Company", "Contakt" or "Contakt World"), a SaaS company committed to improving health equity and access to healthcare while solving sector specific business challenges such as symptom screening and vaccine passports, is pleased to provide a summary of the Company's recent achievements, current operations, and strategic initiatives.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
portum

Contakt World Expands Commercial Portfolio Through Partnership Agreement with Portum for Health Screening, Vaccine Wallet, Vaccine Passport, and More

Contakt World to offer Portum to create safe spaces, healthy places, and peace of mind for all with its digital health pass and vaccine wallet for consumers, businesses, and government

  • A vaccine mandate was recently enacted in the United States for all Federal employees
  • The private sector is following suit, creating demand for Contakt World's portfolio
  • Portum's app offers the public and private sector a unique, integrated solution
  • Contakt World intends to offer the Portum solutions to new and existing customers

Contakt World Technologies Corp. (CSE: HELP) (OTC: TLOOF) (FSE: B2I0) (the "Company" or "Contakt World"), a SaaS company committed to improving health equity and access to healthcare while solving sector specific business challenges such as symptom screening and vaccine passports, today announced it has executed a strategic partnership agreement with Portum System LLC ("Portum").

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
1000 usd to cad

Contakt World Launches Sales Representative Program to Continue to Grow Revenue for Its Cash Flow Positive HealthCheck Screening Tool and Vaccine Passport Solution

Independent sales representatives provide scalable technology sales opportunity for health screening and vaccine passports to Contakt World and its portfolio companies

  • HealthCheck's existing 1,000+ customer sites were acquired through sales efforts of one part-time independent sales representative and two founders leading to $1.55M CAD revenue and $555K CAD net profit for the twelve-months ended July 31, 20211
  • In addition to plans to bolster its revenue opportunities with vaccine passports and validation, Contakt World just launched a program to aggressively add independent sales representatives to scale sales within employer establishments, K-12 schools and event venues in the US
  • Contakt World's advertisements and initial screening process to add independent sales representatives for health screening, vaccine passports, and future solutions yielded dozens of qualified applicants in less than two weeks
  • Independent sales representatives are expected to grow customer base and increase revenue for HealthCheck and future solutions like vaccine passports on a commission-only basis

Contakt World Technologies Corp. (CSE: HELP) (OTC: TLOOF) (FSE: B2I0) (the "Company" or "Contakt World"), a SaaS company committed to improving health equity and access to healthcare while solving sector specific business challenges like symptom screening and vaccine passports, today announced it will create a network of independent sales representatives to scale sales for the recently acquired HealthCheck app, vaccine passports, and future acquisitions or partnering products.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Contakt World to Offer Vaccine Passport and Verification Platform To Employers, Events and Organizations, Including Customers of Recently Acquired HealthCheck App

Contakt World to Offer Vaccine Passport and Verification Platform To Employers, Events and Organizations, Including Customers of Recently Acquired HealthCheck App

HealthCheck app provides an ideal technology environment for combined symptom screening, vaccine passport and verification

  • Contakt World intends to offer existing and new customers integrated tools for vaccine passport and verification.
  • Vaccine passport verification is critical to combat increased fraud  and reduce liability – Contakt World to deliver passport verification solution to ensure accuracy and prevent use of fraudulent vaccine records.
  • Contakt World recently acquired cash flow positive HealthCheck - a health screening tool to assess COVID-19 symptoms quickly and easily via the HealthCheck app - featuring 1,000+ locations in use.
  • News that the Pfizer BioNTech vaccine loses efficacy faster against Delta variant1 suggests a recurring need for boosters, vaccine passports, and health screening for years to come.

Contakt World Technologies Corp. (CSE: HELP) (OTC: TLOOF) (FSE: B2I0) (the "Company" or "Contakt World"), a SaaS company committed to improving health equity and access to healthcare while solving sector specific business challenges, today announced it will leverage the recently acquired HealthCheck app to help combat fraud in vaccine credentials and enable privacy-preserving vaccine passports.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
BioHarvest Sciences Inc. Announces Live Quarterly Shareholder Update Event July 7, 2022, at 2:00 PM ET

BioHarvest Sciences Inc. Announces Live Quarterly Shareholder Update Event July 7, 2022, at 2:00 PM ET

 BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, July 7, 2022, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time).

BioHarvest Sciences CEO Ilan Sobel will host the event, which will include coverage of Q2 sales results and a detailed progress update on the 2022 Growth Priorities, with specific focus on the VINIA scale-up progress in the USA and on the Company's Cannabis market entry strategy into North America.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Nanalysis Announces Results of AGM and Appointment of New Director

Nanalysis Scientific Corp. ("the Company", ("the Company", TSXV: NSCI OTCQX: NSCIF FRA: 1N1 ) a leader in portable NMR machines and MRI technology for healthcare and industrial applications, is pleased to report that all proposed resolutions were approved at the Company's Annual General and Special Meeting of shareholders held on June 22, 2022 (the "Meeting"). The number of directors was set at 7 and all director nominees, as listed in the Management Information Circular dated May 20, 2022 (the "Information Circular"), were elected as directors of the Company at the Meeting to serve for a one-year term and hold office until the next annual meeting of shareholders. According to the proxy votes received from shareholders, the results were as follows:

Nanalysis Scientific Corp. (CNW Group/Nanalysis Scientific Corp.)

Nominees:


% For


% Withheld






Sean Krakiwsky


96.566 %


3.434 %

Martin Burian


95.592 %


4.408 %

Werner Gartner


99.852 %


0.148 %

Michal Okoniewski


99.852 %


0.148 %

Guido Cloetens


95.628 %


4.372 %

Rene Lenggenhager


99.852 %


0.148 %

Kham Lin


99.609 %


0.391 %

Shareholders voted 99.85% in favor of setting the number of directors at seven, 99.6% in favor of appointing Ernst & Young LLP, as auditor of the Company for the ensuing year and to authorize the Directors of the Company to fix the auditor's remuneration and 98.1% in favor for the approval of an amended stock option plan of the Company.

Corporate Update

The Company is pleased to welcome Kham Lin to Nanalysis's Board of Directors with immediate effect following shareholder approval at the Meeting.

Mr. Lin is currently a Managing Director at Nanalysis and was formerly the President and Chief Executive Officer of KPrime Technologies before the Company's acquisition by Nanalysis.  Over twenty plus years, Mr. Lin built KPrime, into a manufacturing representative business for global companies like Agilent Technologies, Metrohm USA , Sartorius LPS Division, and Leidos.  KPrime has a portfolio of sales and services in scientific detection and measuring equipment, financing, and asset management for chemical and security industries.  Mr. Lin resides and works in Calgary, Alberta, Canada but also splits time in Phoenix, Arizona at KPrime Headquarters.

About Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA:1N1)

Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI', OTC and the Frankfurt exchange under the ticker symbol '1N1'. The company's business is what we term "MRI and NMR for industry". The company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. Nanalysis recently announced that it has begun selling a 100MHz device in 2020. The Company's new device will be the most powerful and most advanced compact NMR device ever brought to market.

Nanalysis devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.

With the recent acquisition of K'Prime, the company maintains a North American sales and service company of over 40 individuals who cover scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications.

Additionally, the Company has a 43% ownership in Quad Systems AG ("Quad Systems"), with an option to purchase the remaining shares.  Quad Systems is a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/nanalysis-announces-results-of-agm-and-appointment-of-new-director-301574013.html

SOURCE Nanalysis Scientific Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2022/23/c9517.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Applied UV Continues Cannabis Market Expansion

Applied UV Continues Cannabis Market Expansion

Tru Infusion Places Significant Order

Largest Indoor Cannabis Cultivator in Arizona

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Greenlane Renewables Announces Results From 2022 Annual General Meeting of Shareholders

Greenlane Renewables Announces Results From 2022 Annual General Meeting of Shareholders

~All nominated directors and proposed resolutions approved by shareholders~

 Greenlane Renewables Inc. ("Greenlane") (TSX: GRN) (FSE: 52G) is pleased to announce the results from its 2022 Annual General Meeting of Shareholders held on June 22, 2022 (the "Meeting"). Shareholders approved all matters submitted to them for approval at the annual general meeting. The results of the voting are set forth below:

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Applied UV Receives Substantial Order from European Distributor

Applied UV Receives Substantial Order from European Distributor

Cellarius is One of Europe's Fastest Growing Companies

Expanding Airocide's Global Winery Market share

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Playground Ventures Announces Appointment of CFO

Playground Ventures Announces Appointment of CFO

Playground Ventures Inc. (CSE: PLAY) (the "Company" or "Playground") announces that Nidhi Kumra has resigned as the Company's Chief Financial Officer, effectively May 31, 2022. The Board of Directors and management would like to thank Ms. Kumra for her contributions to the Company and wish her every success in her future endeavors.

The Company is also pleased to announce that Kaylee Whitcroft, the Company's Operations Accounting Manager, has been appointed the Chief Financial Officer of the Company.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×